Phase I clinical trials in oncology

被引：0
|
作者：
Ganesan, Prasanth [1 ]
机构：
[1] JIPMER, Dept Med Oncol, Pondicherry, India
来源：
INDIAN JOURNAL OF MEDICAL AND PAEDIATRIC ONCOLOGY | 2020年 / 41卷 / 06期
关键词：
D O I：
10.4103/ijmpo.ijmpo_7_20
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：885 / 888
页数：4
相关论文
共 50 条
  • [41] Natural Language Processing for Patient Selection in Phase I or II Oncology Clinical Trials
    Delorme, Julie
    Charvet, Valentin
    Wartelle, Muriel
    Lion, Francois
    Thuillier, Bruno
    Mercier, Sandrine
    Soria, Jean-Charles
    Azoulay, Mikael
    Besse, Benjamin
    Massard, Christophe
    Hollebecque, Antoine
    Verlingue, Loic
    JCO CLINICAL CANCER INFORMATICS, 2021, 5 : 709 - 718
  • [42] Bayesian hybrid dose-finding design in phase I oncology clinical trials
    Yuan, Ying
    Yin, Guosheng
    STATISTICS IN MEDICINE, 2011, 30 (17) : 2098 - 2108
  • [43] A web application for optimal selection of adaptive designs in phase I oncology clinical trials
    Chen, Sheau-Chiann
    Shyr, Yu
    TRIALS, 2017, 18
  • [44] A Survey of the Way Pharmacokinetics are Reported in Published Phase I Clinical Trials, with an Emphasis on Oncology
    Comets, Emmanuelle
    Zohar, Sarah
    CLINICAL PHARMACOKINETICS, 2009, 48 (06) : 387 - 395
  • [45] Clinical benefits and risks of phase I oncology trials: experience from a single institution
    Gollamudi, R.
    Wong, B. M.
    Ghalib, M. H.
    Kumar, M.
    Desai, K.
    Chaudhary, I.
    Goel, S.
    Mani, S.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [46] The Use of Patient-Reported Outcome Measures in Phase I Oncology Clinical Trials
    Coleman, Robert L.
    Beck, J. Thaddeus
    Baranda, Joaquina C.
    Jacobs, Ira
    Smoyer, Karen E.
    Lee, Lauren J.
    Askerova, Zemfira
    McGinnis, Justin
    Ganti, Apar Kishor
    ONCOLOGY, 2021, : 444 - 453
  • [47] Ethical Considerations in Pediatric Oncology Phase I Clinical Trials According to The Belmont Report
    Haylett, Wendy J.
    JOURNAL OF PEDIATRIC ONCOLOGY NURSING, 2009, 26 (02) : 107 - 112
  • [48] Reporting and impact of subsequent cycle toxicities in oncology phase I clinical trials.
    Rami, Avina
    DuBois, Steven G.
    Campbell, Kevin M.
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [49] PROGNOSTICATION OF PEDIATRIC ONCOLOGY PATIENTS ENROLLED IN PHASE I CLINICAL TRIALS DESIGNED FOR ADULTS
    Subbiah, V.
    Corrales-Medina, F.
    Herzog, C. E.
    Hess, K.
    Anderson, P. M.
    Huh, W. W.
    Kleinerman, E.
    Kurzrock, R.
    PEDIATRIC BLOOD & CANCER, 2014, 61 : S210 - S210
  • [50] A Survey of the Way Pharmacokinetics are Reported in Published Phase I Clinical Trials, with an Emphasis on Oncology
    Emmanuelle Comets
    Sarah Zohar
    Clinical Pharmacokinetics, 2009, 48 : 387 - 395
12345